IgM and IgA rheumatoid factors purified from rheumatoid arthritis sera boost the Fc receptor- and complement-dependent effector functions of the disease-specific anti-citrullinated protein autoantibodies

Journal of Immunology

Volumn 194, Issue 8, 2015, Pages 3664-3674

  Anquetil, Florence ^a,b,c,d   Clavel, Cyril ^a,b,c,d   Offer, Géraldine ^a,b,c   Serre, Guy ^a,b,c,d   Sebbag, Mireille ^a,b,c  

^a France   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; FC ALPHA RECEPTOR I; FC RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ALPHA; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; COMPLEMENT; CYTOKINE; IMMUNOGLOBULIN G;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; SYNOVITIS; CHEMICALLY INDUCED; COMPLEMENT ACTIVATION; DRUG EFFECTS; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; PATHOLOGY;

ARTHRITIS, RHEUMATOID; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; RECEPTORS, FC; RHEUMATOID FACTOR; SYNOVITIS;

EID: 84927587432     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402334     Document Type: Article

References (70)

1. Brennan, F. M., and I. B. McInnes. 2008. Evidence that cytokines play a role in rheumatoid arthritis. J. Clin. Invest. 118:3537-3545.
2. Chu, C. Q., M. Field, M. Feldmann, and R. N. Maini. 1991. Localization of tumor necrosis factor a in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum. 34:1125-1132.
3. Jovanovic, D. V., J. A. Di Battista, J. Martel-Pelletier, F. C. Jolicoeur, Y. He, M. Zhang, F. Mineau, and J.-P. Pelletier. 1998. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-b and TNF-a, by human macrophages. J. Immunol. 160:3513-3521.
4. Brennan, F., and A. Foey. 2002. Cytokine regulation in RA synovial tissue: role of T cell/macrophage contact-dependent interactions. Arthritis Res. 4 (Suppl. 3):S177-S182.
5. Tran, C. N., S. K. Lundy, and D. A. Fox. 2005. Synovial biology and T cells in rheumatoid arthritis. Pathophysiology 12:183-189.
6. H17 cell generation. PLoS Biol. 10:e1001395.
7. Goh, F. G., and K. S. Midwood. 2012. Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis. Rheumatology (Oxford) 51:7-23.
8. Schoels, M., C. Bombardier, and D. Aletaha. 2011. Diagnostic and prognostic value of antibodies and soluble biomarkers in undifferentiated peripheral inflammatory arthritis: a systematic review. J. Rheumatol. Suppl. 87:20-25.
9. Taylor, P., J. Gartemann, J. Hsieh, and J. Creeden. 2011. A systematic review of serum biomarkers anti-cyclic citrullinated peptide and rheumatoid factor as tests for rheumatoid arthritis. Autoimmune Dis. 2011:815038.
10. Masson-Bessière, C., M. Sebbag, J. J. Durieux, L. Nogueira, C. Vincent, E. Girbal-Neuhauser, R. Durroux, A. Cantagrel, and G. Serre. 2000. In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin. Exp. Immunol. 119:544-552.
11. Iwaki-Egawa, S., H. Matsuno, Y. Ogawa, and Y. Watanabe. 2005. Production of anti-CCP antibodies and matrix metalloproteinase-3 by human rheumatoid arthritis synovial tissues using SCID mice. Ann. Rheum. Dis. 64:1094-1095.
12. Tilleman, K., K. Van Steendam, T. Cantaert, F. De Keyser, D. Elewaut, and D. Deforce. 2008. Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides. Rheumatology (Oxford) 47:597-604.
13. Masson-Bessière, C., M. Sebbag, E. Girbal-Neuhauser, L. Nogueira, C. Vincent, T. Senshu, and G. Serre. 2001. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the a- and b-chains of fibrin. J. Immunol. 166:4177-4184.
14. Hermansson, M., K. Artemenko, E. Ossipova, H. Eriksson, J. Lengqvist, D. Makrygiannakis, A. I. Catrina, A. P. Nicholas, L. Klareskog, M. Savitski, et al. 2010. MS analysis of rheumatoid arthritic synovial tissue identifies specific citrullination sites on fibrinogen. Proteomics Clin. Appl. 4:511-518.
15. Raijmakers, R., J. J. Van Beers, M. El-Azzouny, N. F. Visser, B. Božič, G. J. Pruijn, and A. J. Heck. 2012. Elevated levels of fibrinogen-derived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patients. Arthritis Res. Ther. 14:R114.
16. Van Beers, J. J., C. M. Schwarte, J. Stammen-Vogelzangs, E. Oosterink, B. Božič, and G. J. Pruijn. 2013. The rheumatoid arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear differentiation antigen, and b-actin. Arthritis Rheum. 65:69-80.
17. Van Beers, J. J., A. Willemze, J. Stammen-Vogelzangs, J. W. Drijfhout, R. E. Toes, and G. J. Pruijn. 2012. Anti-citrullinated fibronectin antibodies in rheumatoid arthritis are associated with human leukocyte antigen-DRB1 shared epitope alleles. Arthritis Res. Ther. 14:R35.
18. Vossenaar, E. R., T. R. Radstake, A. Van Der Heijden, M. A. Van Mansum, C. Dieteren, D. J. De Rooij, P. Barrera, A. J. Zendman, and W. J. Van Venrooij. 2004. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann. Rheum. Dis. 63:373-381.
19. Foulquier, C., M. Sebbag, C. Clavel, S. Chapuy-Regaud, R. Al Badine, M. C. Méchin, C. Vincent, R. Nachat, M. Yamada, H. Takahara, et al. 2007. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum. 56:3541-3553.
20. Trouw, L. A., E. M. Haisma, E. W. Levarht, D. Van Der Woude, A. Ioan-Facsinay, M. R. Daha, T. W. Huizinga, and R. E. Toes. 2009. Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum. 60:1923-1931.
21. Clavel, C., L. Nogueira, L. Laurent, C. Iobagiu, C. Vincent, M. Sebbag, and G. Serre. 2008. Induction of macrophage secretion of tumor necrosis factor a through Fcg receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis Rheum. 58:678-688.
22. Sokolove, J., X. Zhao, P. E. Chandra, and W. H. Robinson. 2011. Immune complexes containing citrullinated fibrinogen costimulate macrophages via Tolllike receptor 4 and Fcg receptor. Arthritis Rheum. 63:53-62.
23. Mellors, R. C., R. Heimer, J. Corcos, and L. Korngold. 1959. Cellular origin of rheumatoid factor. J. Exp. Med. 110:875-886.
24. Fehr, K., M. Velvart, M. Rauber, M. Knöpfel, A. Baici, P. Salgam, and A. Bö Ni. 1981. Production of agglutinators and rheumatoid factors in plasma cells of rheumatoid and nonrheumatoid synovial tissues. Arthritis Rheum. 24:510-519.
25. Koopman, W. J., R. E. Schrohenloher, S. S. Crago, D. M. Spalding, and J. Mestecky. 1985. IgA rheumatoid factor synthesis by dissociated synovial cells. Characterization and relationship to IgM rheumatoid factor synthesis. Arthritis Rheum. 28:1219-1227.
26. Panush, R. S., A. K. Bittner, M. Sullivan, P. Katz, and S. Longley. 1985. IgM rheumatoid factor elaboration by blood, bone marrow, and synovial mononuclear cells in patients with rheumatoid arthritis. Clin. Immunol. Immunopathol. 34:387-391.
27. Wernick, R. M., P. E. Lipsky, E. Marban-Arcos, J. J. Maliakkal, D. Edelbaum, and M. Ziff. 1985. IgG and IgM rheumatoid factor synthesis in rheumatoid synovial membrane cell cultures. Arthritis Rheum. 28:742-752.
28. Soden, M., A. Whelan, C. Feighery, and B. Bresnihan. 1990. Lymphocyte infiltration and the synthesis of IgM and IgA rheumatoid factors by rheumatoid synovial membrane. Rheumatol. Int. 10:149-152.
29. Schrohenloher, R. E. 1988. IgG as antigen in human rheumatoid disease. Scand. J. Rheumatol. Suppl. 75:133-139.
30. Soltys, A. J., F. C. Hay, A. Bond, J. S. Axford, M. G. Jones, I. Randen, K. M. Thompson, and J. B. Natvig. 1994. The binding of synovial tissue-derived human monoclonal immunoglobulin M rheumatoid factor to immunoglobulin G preparations of differing galactose content. Scand. J. Immunol. 40:135-143.
31. Parekh, R. B., R. A. Dwek, B. J. Sutton, D. L. Fernandes, A. Leung, D. Stanworth, T. W. Rademacher, T. Mizuochi, T. Taniguchi, K. Matsuta, et al. 1985. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316:452-457.
32. Scherer, H. U., D. Van Der Woude, A. Ioan-Facsinay, H. El Bannoudi, L. A. Trouw, J. Wang, T. Häupl, G. R. Burmester, A. M. Deelder, T. W. Huizinga, et al. 2010. Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid. Arthritis Rheum. 62:1620-1629.
33. Laurent, L., F. Anquetil, C. Clavel, N. Ndongo-Thiam, G. Offer, P. Miossec, J. L. Pasquali, M. Sebbag, and G. Serre. 2014. IgM rheumatoid factor amplifies the inflammatory response of macrophages induced by the rheumatoid arthritisspecific immune complexes containing anticitrullinated protein antibodies. Ann. Rheum. Dis. In press 10.1136/annrheumdis-2013-204543.
34. Jónsson, T., K. Steinsson, H. Jónsson, A. J. Geirsson, J. Thorsteinsson, and H. Valdimarsson. 1998. Combined elevation of IgM and IgA rheumatoid factor has high diagnostic specificity for rheumatoid arthritis. Rheumatol. Int. 18:119-122.
35. Swedler, W., J. Wallman, C. J. Froelich, and M. Teodorescu. 1997. Routine measurement of IgM, IgG, and IgA rheumatoid factors: high sensitivity, specificity, and predictive value for rheumatoid arthritis. J. Rheumatol. 24:1037-1044.
36. Pasquali, J. L., A. M. Knapp, A. Farradji, and A. Weryha. 1987. Mapping of four light chain-associated idiotopes of a human monoclonal rheumatoid factor. J. Immunol. 139:818-823.
37. Pleass, R. J., T. Areschoug, G. Lindahl, and J. M. Woof. 2001. Streptococcal IgA-binding proteins bind in the Ca2-Ca3 interdomain region and inhibit binding of IgA to human CD89. J. Biol. Chem. 276:8197-8204.
38. Magalhães, P. O., A. M. Lopes, P. G. Mazzola, C. Rangel-Yagui, T. C. Penna, and A. Pessoa, Jr. 2007. Methods of endotoxin removal from biological preparations: a review. J. Pharm. Pharm. Sci. 10:388-404.
39. Normansell, D. E., and D. R. Stanworth. 1966. Ultracentrifugal studies of the reactions of rheumatoid factor with native human gG-globulin. Immunology 10:527-533.
40. Lood, C., M. Allhorn, R. Lood, B. Gullstrand, A. I. Olin, L. Rönnblom, L. Truedsson, M. Collin, and A. A. Bengtsson. 2012. IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: a possible new treatment? Arthritis Rheum. 64:2698-2706.
41. Shibuya, A., N. Sakamoto, Y. Shimizu, K. Shibuya, M. Osawa, T. Hiroyama, H. J. Eyre, G. R. Sutherland, Y. Endo, T. Fujita, et al. 2000. Fca/m receptor mediates endocytosis of IgM-coated microbes. Nat. Immunol. 1:441-446.
42. Kubagawa, H., S. Oka, Y. Kubagawa, I. Torii, E. Takayama, D. W. Kang, G. L. Gartland, L. F. Bertoli, H. Mori, H. Takatsu, et al. 2009. Identity of the elusive IgM Fc receptor (FcmR) in humans. J. Exp. Med. 206:2779-2793.
43. Jefferis, R., and J. Lund. 2002. Interaction sites on human IgG-Fc for FcgR: current models. Immunol. Lett. 82:57-65.
44. Sasso, E. H., C. V. Barber, F. A. Nardella, W. J. Yount, and M. Mannik. 1988. Antigenic specificities of human monoclonal and polyclonal IgM rheumatoid factors. The Cg2-Cg3 interface region contains the major determinants. J. Immunol. 140:3098-3107.
45. Bonagura, V. R., S. E. Artandi, A. Davidson, I. Randen, N. Agostino, K. Thompson, J. B. Natvig, and S. L. Morrison. 1993. Mapping studies reveal unique epitopes on IgG recognized by rheumatoid arthritis-derived monoclonal rheumatoid factors. J. Immunol. 151:3840-3852.
46. Corper, A. L., M. K. Sohi, V. R. Bonagura, M. Steinitz, R. Jefferis, A. Feinstein, D. Beale, M. J. Taussig, and B. J. Sutton. 1997. Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction. Nat. Struct. Biol. 4:374-381.
47. Duquerroy, S., E. A. Stura, S. Bressanelli, S. M. Fabiane, M. C. Vaney, D. Beale, M. Hamon, P. Casali, F. A. Rey, B. J. Sutton, and M. J. Taussig. 2007. Crystal structure of a human autoimmune complex between IgM rheumatoid factor RF61 and IgG1 Fc reveals a novel epitope and evidence for affinity maturation. J. Mol. Biol. 368:1321-1331.
48. Wines, B. D., A. Gavin, M. S. Powell, M. Steinitz, R. R. Buchanan, and P. Mark Hogarth. 2003. Soluble FcgRIIa inhibits rheumatoid factor binding to immune complexes. Immunology 109:246-254.
49. Viré, B., A. David, and A. Wiestner. 2011. TOSO, the Fcm receptor, is highly expressed on chronic lymphocytic leukemia B cells, internalizes upon IgM binding, shuttles to the lysosome, and is downregulated in response to TLR activation. J. Immunol. 187:4040-4050.
50. Shibuya, A., and S. Honda. 2006. Molecular and functional characteristics of the Fca/mR, a novel Fc receptor for IgM and IgA. Springer Semin. Immunopathol. 28:377-382.
51. Boyle, J. J., I. Christou, M. B. Iqbal, A. T. Nguyen, V. W. Leung, P. C. Evans, Y. Liu, M. Johns, P. Kirkham, and D. O. Haskard. 2012. Solid-phase immunoglobulins IgG and IgM activate macrophages with solid-phase IgM acting via a novel scavenger receptor a pathway. Am. J. Pathol. 181:347-361.
52. Adachi, T., S. Harumiya, H. Takematsu, Y. Kozutsumi, M. Wabl, M. Fujimoto, and T. F. Tedder. 2012. CD22 serves as a receptor for soluble IgM. Eur. J. Immunol. 42:241-247.
53. Lux, A., X. Yu, C. N. Scanlan, and F. Nimmerjahn. 2013. Impact of immune complex size and glycosylation on IgG binding to human FcgRs. J. Immunol. 190:4315-4323.
54. Chapuy-Regaud, S., L. Nogueira, C. Clavel, M. Sebbag, C. Vincent, and G. Serre. 2003. Subclass distribution of IgG autoantibodies to deiminated fibrinogen in rheumatoid arthritis. Arthritis Res. Ther. 5:4. doi:10.1186/ar634
55. Hamre, R., I. N. Farstad, P. Brandtzaeg, and H. C. Morton. 2003. Expression and modulation of the human immunoglobulin A Fc receptor (CD89) and the FcR g chain on myeloid cells in blood and tissue. Scand. J. Immunol. 57:506-516.
56. Monteiro, R. C., and J. G. Van De Winkel. 2003. IgA Fc receptors. Annu. Rev. Immunol. 21:177-204.
57. Smiley, S. T., J. A. King, and W. W. Hancock. 2001. Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J. Immunol. 167:2887-2894.
58. Hodgkinson, C. P., K. Patel, and S. Ye. 2008. Functional Toll-like receptor 4 mutations modulate the response to fibrinogen. Thromb. Haemost. 100:301-307.
59. Erridge, C. 2010. Endogenous ligands of TLR2 and TLR4: agonists or assistants? J. Leukoc. Biol. 87:989-999.
60. Hamilton, J. A. 2008. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 8:533-544.
61. Li, J., H. C. Hsu, and J. D. Mountz. 2012. Managing macrophages in rheumatoid arthritis by reform or removal. Curr. Rheumatol. Rep. 14:445-454.
62. Neumann, E., S. R. Barnum, I. H. Tarner, J. Echols, M. Fleck, M. Judex, F. Kullmann, J. D. Mountz, J. Schölmerich, S. Gay, and U. Müller-Ladner. 2002. Local production of complement proteins in rheumatoid arthritis synovium. Arthritis Rheum. 46:934-945.
63. Okroj, M., D. Heinegård, R. Holmdahl, and A. M. Blom. 2007. Rheumatoid arthritis and the complement system. Ann. Med. 39:517-530.
64. Sabharwal, U. K., J. H. Vaughan, S. Fong, P. H. Bennett, D. A. Carson, and J. G. Curd. 1982. Activation of the classical pathway of complement by rheumatoid factors. Assessment by radioimmunoassay for C4. Arthritis Rheum. 25:161-167.
65. Sato, Y., H. Watanabe, A. Kogure, M. Miyata, K. Watanabe, T. Nishimaki, R. Kasukawa, and T. Fujita. 1995. Complement-activating properties of IgM rheumatoid factors reacting with IgG subclasses. Clin. Rheumatol. 14:425-428.
66. Jones, V. E., R. K. Jacoby, P. J. Cowley, and C. Warren. 1982. Immune complexes in early arthritis. II. Immune complex constituents are synthesized in the synovium before rheumatoid factors. Clin. Exp. Immunol. 49:31-40.
67. Nielen, M. M., D. Van Schaardenburg, H. W. Reesink, R. J. Van De Stadt, I. E. Van Der Horst-Bruinsma, M. H. De Koning, M. R. Habibuw, J. P. Vandenbroucke, and B. A. Dijkmans. 2004. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 50:380-386.
68. Li, W., M. Wang, P. Irigoyen, and P. K. Gregersen. 2006. Inferring causal relationships among intermediate phenotypes and biomarkers: a case study of rheumatoid arthritis. Bioinformatics 22:1503-1507.
69. Sokolove, J., D. S. Johnson, L. J. Lahey, C. A. Wagner, D. Cheng, G. M. Thiele, K. Michaud, H. Sayles, A. M. Reimold, L. Caplan, et al. 2014. Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis. Arthritis Rheum. 66:813-821.
70. Hecht, C., M. Englbrecht, J. Rech, S. Schmidt, E. Araujo, K. Engelke, S. Finzel, and G. Schett. 2014. Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA. Ann. Rheum. Dis. In press 10.1136/annrheumdis-2014-205428.